Medical Research
Antibiotic Resistance Issues
Labor, Health and Human Services (LHHS) Appropriations
HR 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 - Budget Resolutions FY09
H. Con. Res. 85 - Budget Resolutions FY09 Senate and House comprehensive health reform bills
FDA regulations affecting MRSA products; FDA Hatch-Waxman and patent issues; Comparative Effectiveness research; ARRA
S. 525, HR 1298 - Drug Importation
Follow-on biologics - HR 1427, HR 1548, S 726 HR 1191, HR 1359, S. 1292, S. 1336 - disposal of drugs
S. 301 - Physicians payments
Anti counterfeiting legislation 
Medical Research
Antibiotic Resistance Issues
Kennedy Healthcare Reform Bill
House Tri Committee Healthcare Reform Bill
Tri Caucus Healthcare Reform Bill
Senate Finance Healthcare Reform Bill
S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009
HR 2400 Strategies to Address Antimicrobial Resistance Act (STAAR)
HR 2937 MRSA Infection Prevention and Patient Protection Act
HR 2502 Comparative Effectiveness Research Act of 2009
S. 1213 Patient-Centered Outcomes Research Act of 2009 HR 574 Medicare Home Infusion Therapy Coverage Act of 2009
S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
S. 515, HR 1260 - Patent Reform
S. 369, H.R. 1706 - Patent Settlements Medicare In-Patient Hospital Payment Procedures
Medicare Coverage Issues
HR 574 Medicare Home Infusion Therapy Coverage Act of 2009
S. 254 Medicare Home Infusion Therapy Coverage Act of 2009 S. 301 Physician Payments Sunshine Act of 2009
Kennedy Healthcare Reform Bill
House Tri-Committee Healthcare Reform Bill
Tri Caucus Healthcare Reform Bill
Senate Finance Healthcare Reform Bill
S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009
HR 2501 Comparative Effectiveness Act of 2009
S. 1213 Patient-Centered Outcomes Research Act of 2009 Medical Research
Prescription Drug/Federal Drug Admin/Center for Disease Control/Health and Human Services Issues
Antibiotic Resistance Issues
HR 2400 Strategies to Address Antimicrobial Resistance Act (STAAR) HR 2937 MRSA Infection Prevention and Patient Protection Act
BUD - Budget/Appropriations HCR - Health Issues CPT - Copyright/Patent/Trademark MMM - Medicare/Medicaid PHA - Pharmacy
136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CUBIST PHARMACEUTICALS, INC.
65 Hayden Avenue, Lexington, MA, 02421, US
MARK THOMAS BATTAGLINI (Mike Enzi, Sr. Senator, WY Congressional Fellow) MARK THOMAS BATTAGLINI (Mike Enzi, Sr. Senator WY, Congressional Fellow) MARK THOMAS BATTAGLINI (Mike Enzi, Sr. Senator WY, Congressional Fellow) MARK THOMAS BATTAGLINI (Mike Enzi, Sr. Senator, WY, Congressional Fellow) MARK THOMAS BATTAGLINI (Mike Enzi, Sr. Senator, WY, Congressional Fellow)
Mike Enzi, Sr. Senator, WY Congressional Fellow Mike Enzi, Sr. Senator WY, Congressional Fellow Mike Enzi, Sr. Senator WY, Congressional Fellow Mike Enzi, Sr. Senator, WY, Congressional Fellow Mike Enzi, Sr. Senator, WY, Congressional Fellow